Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sue Wells

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Journal of Primary Health Care|August 10, 2010
Cardiovascular disease risk profile tools and New Zealand--absolutely the best way forwardSue Wells, Tania Riddell, Rod Jackson
Lancet (London, England)|December 14, 2020
Cardiovascular preventive strategies are not conflictingRod Jackson, Sue Wells, Anthony Rodgers
BMJ (Clinical Research Ed.)|August 30, 2008
Will screening individuals at high risk of cardiovascular events deliver large benefits? YesRod Jackson, Sue Wells, Anthony Rodgers
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|November 3, 2007
Zero end-digit preference in recorded blood pressure and its impact on classification of patients for pharmacologic management in primary care - PREDICT-CVD-6Joanna Broad, Sue Wells, Roger Marshall, et al.
Plos Medicine|September 3, 2010
Harnessing health IT for improved cardiovascular risk managementSue Wells, Robyn Whittaker, Enid Dorey, et al.
Australian and New Zealand Journal of Public Health|August 8, 2007
Agreement between ethnicity recorded in two New Zealand health databases: effects of discordance on cardiovascular outcome measures (PREDICT CVD3)Roger J Marshall, Zhongqian Zhang, Joanna B Broad, et al.
The New Zealand Medical Journal|March 31, 2015
Removal of Special Authority requirements for clopidogrel improved optimal care following percutaneous coronary intervention across sociodemographic groupsSuneela Mehta, Sue Wells, Rod Jackson, et al.
The New Zealand Medical Journal|October 14, 2016
The effect of removing funding restrictions for atorvastatin differed across sociodemographic groups among New Zealanders hospitalised with cardiovascular disease: a national data linkage studySuneela Mehta, Sue Wells, Rod Jackson, et al.
The New Zealand Medical Journal|October 26, 2018
Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease?Vanessa Selak, Rod Jackson, Katrina Poppe, et al.
BMJ (Clinical Research Ed.)|July 9, 2009
QRISK or Framingham for predicting cardiovascular risk?Rod Jackson, Roger Marshall, Andrew Kerr, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Journal of Primary Health Care|August 10, 2010
Cardiovascular disease risk profile tools and New Zealand--absolutely the best way forwardSue Wells, Tania Riddell, Rod Jackson
Lancet (London, England)|December 14, 2020
Cardiovascular preventive strategies are not conflictingRod Jackson, Sue Wells, Anthony Rodgers
BMJ (Clinical Research Ed.)|August 30, 2008
Will screening individuals at high risk of cardiovascular events deliver large benefits? YesRod Jackson, Sue Wells, Anthony Rodgers
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|November 3, 2007
Zero end-digit preference in recorded blood pressure and its impact on classification of patients for pharmacologic management in primary care - PREDICT-CVD-6Joanna Broad, Sue Wells, Roger Marshall, et al.
Plos Medicine|September 3, 2010
Harnessing health IT for improved cardiovascular risk managementSue Wells, Robyn Whittaker, Enid Dorey, et al.
Australian and New Zealand Journal of Public Health|August 8, 2007
Agreement between ethnicity recorded in two New Zealand health databases: effects of discordance on cardiovascular outcome measures (PREDICT CVD3)Roger J Marshall, Zhongqian Zhang, Joanna B Broad, et al.
The New Zealand Medical Journal|March 31, 2015
Removal of Special Authority requirements for clopidogrel improved optimal care following percutaneous coronary intervention across sociodemographic groupsSuneela Mehta, Sue Wells, Rod Jackson, et al.
The New Zealand Medical Journal|October 14, 2016
The effect of removing funding restrictions for atorvastatin differed across sociodemographic groups among New Zealanders hospitalised with cardiovascular disease: a national data linkage studySuneela Mehta, Sue Wells, Rod Jackson, et al.
The New Zealand Medical Journal|October 26, 2018
Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease?Vanessa Selak, Rod Jackson, Katrina Poppe, et al.
BMJ (Clinical Research Ed.)|July 9, 2009
QRISK or Framingham for predicting cardiovascular risk?Rod Jackson, Roger Marshall, Andrew Kerr, et al.
Pageof 9